Blog

Q&A – The Must-Haves of FDA and Common Rule Reporting Requirements

October 14, 2020

In a recent webinar, Advarra regulatory experts discussed the must-haves of FDA and Common Rule reporting requirements. They reviewed the basics of what must be reported to whom—and when—for sponsors…

Oct271 pm ET
Webinar

Racial Diversity in Clinical Trials: Building Trust in Participant Engagement

COVID-19 has focused the importance of diversity, equity, and inclusion considerations in clinical trial enrollment. How can the research community address the root causes for lack of diversity? What actions…

Case Study

Global CRO Drives Study Startup Efficiency by Converting Local IRB Sites to Central IRB Review

October 4, 2020

Research sites that rely on a local IRB typically take at least twice as long to activate than sites that rely on the study’s single central IRB. Utilizing the central…

Blog

Q&A – The New Urgency of Clinical Trials: How Oncology Leads the Evolution

September 28, 2020

In Advarra’s recent virtual symposium, experts from industry and academia met to discuss how oncology research has influenced agility in clinical trial design, particularly during the COVID-19 pandemic. Panelists talked…

Info Sheet

IRB Services: Central Oncology Review

September 21, 2020

Advarra’s Central Oncology Review service provides robust human subject protections review that cancer research institutions expect.

Blog

Getting “Engaged” in the Time of COVID

September 16, 2020

When using remote sites to perform clinical trial procedures, there are certain issues researchers must keep in mind, including whether those remote sites are considered to be engaged in research.

Webinar

The Must-Haves of FDA and Common Rule Reporting Requirements

The Food and Drug Administration (FDA) regulations governing Investigational New Drug (IND) applications contain specific reporting requirements. Similarly, the Common Rule (i.e., the federal policy for the protection of human…

Blog

Community Consultation in the Time of COVID-19

September 2, 2020

How should sites conducting planned emergency research approach community consultation in the time of COVID-19?

Blog

How Oncology Research Is Advancing Better Research

August 26, 2020

The COVID-19 pandemic has challenged every aspect of the clinical research industry. This new urgency has affirmed certain clinical trial innovations originally pioneered in the oncology space.

Virtual Event

The New Urgency of Clinical Trials: How Oncology Leads the Evolution

Join colleagues from the research community for a discussion on the evolution of clinical trials and how oncology research has influenced agility in clinical trial design.